|
Net income (loss)
|
|
($91.1m)
|
($122.7m)
|
($94.7m)
|
($62.3m)
|
($54.8m)
|
$554k
|
|
Depreciation
|
|
$1.5m
|
$1.3m
|
$1.4m
|
$1.5m
|
$1.2m
|
$1.3m
|
|
Amortization of intangible assets
|
|
$0
|
$550k
|
$10.8m
|
$10.8m
|
$10.8m
|
$10.8m
|
|
Amortization of premium/discount on investments
|
|
($84k)
|
($413k)
|
($184k)
|
($1.3m)
|
($747k)
|
$0
|
|
Amortization of debt discount and debt issuance costs
|
|
$980k
|
$961k
|
$1.6m
|
$2.2m
|
$3.0m
|
$3.4m
|
|
Amortization of operating right-of-use assets
|
|
—
|
$0
|
$426k
|
$830k
|
$555k
|
$537k
|
|
Deferred income tax expense (benefit)
|
|
—
|
$0
|
($1.4m)
|
($1.2m)
|
($2.3m)
|
$0
|
|
Loss on debt extinguishment, net
|
|
($443k)
|
$0
|
($1.2m)
|
$2.8m
|
$0
|
$0
|
|
Operating lease liabilities
|
|
—
|
$0
|
($899k)
|
$7.5m
|
$1.1m
|
($1.6m)
|
|
Stock-based compensation
|
|
$8.3m
|
$11.4m
|
$12.2m
|
$10.7m
|
$18.4m
|
$22.4m
|
|
Change in fair value of contingent value rights
|
|
—
|
$0
|
$3.2m
|
($5.2m)
|
($4.4m)
|
$0
|
|
Other
|
|
$3.2m
|
($1.4m)
|
$2.5m
|
$3.4m
|
($1.1m)
|
$3.7m
|
|
Trade accounts receivable
|
|
$2.2m
|
$6.2m
|
$13.4m
|
($8.4m)
|
($1.2m)
|
($10.6m)
|
|
Prepaid expenses and other current assets
|
|
($925k)
|
($3.3m)
|
$3.9m
|
$3.2m
|
($1.7m)
|
($2.1m)
|
|
Inventory
|
|
$5.1m
|
$7.4m
|
$7.5m
|
($14.8m)
|
($8.8m)
|
($19.3m)
|
|
Accounts payable
|
|
($2.5m)
|
$5.5m
|
($4.3m)
|
$7.0m
|
($9.6m)
|
($69k)
|
|
Other accrued liabilities
|
|
($2.2m)
|
$12.6m
|
($11.4m)
|
($5.9m)
|
$3.6m
|
$3.3m
|
|
Accrued trade discounts and rebates
|
|
$4.6m
|
$4.2m
|
$1.8m
|
$5.3m
|
$3.9m
|
$16.4m
|
|
Accrued returns reserve
|
|
$932k
|
$1.1m
|
$7.2m
|
$3.0m
|
$4.9m
|
($113k)
|
|
Increase (Decrease) In Supply Agreement Liabilities
|
|
—
|
$0
|
($5.3m)
|
($6.7m)
|
$0
|
$0
|
|
Proceeds from issuance of employee stock purchase plan shares
|
|
$669k
|
$642k
|
$828k
|
$549k
|
$1.2m
|
$1.5m
|
|
Proceeds from exercise of stock options
|
|
$135k
|
$193k
|
$8k
|
$32k
|
$489k
|
$11.6m
|
|
Proceeds from Issuance of Warrants
|
|
—
|
—
|
—
|
$0
|
$0
|
$9.2m
|
|
Issuance of common shares in settlement of CVR liability
|
|
—
|
—
|
$0
|
$0
|
$15.8m
|
$0
|
|
Issuance of convertible note
|
|
—
|
$0
|
$0
|
$33.6m
|
$0
|
$0
|
|
Restricted cash included in Other assets (1)
|
|
—
|
$0
|
$4.3m
|
$4.2m
|
$4.1m
|
$4.0m
|
|
Net cash provided by (used in) operating activities
|
|
($80.6m)
|
($95.5m)
|
($102.9m)
|
($47.0m)
|
($37.0m)
|
$28.6m
|
|
Capital expenditures
|
|
$377k
|
$1.1m
|
($524k)
|
($2.3m)
|
($868k)
|
($696k)
|
|
Purchases of investments
|
|
($101.8m)
|
($43.0m)
|
$0
|
($43.7m)
|
($34.5m)
|
$0
|
|
Sales and maturities of investments
|
|
$74.7m
|
$103.6m
|
$35.0m
|
$40.0m
|
$40.2m
|
$0
|
|
Net cash provided by (used in) investing activities
|
|
($27.4m)
|
$98.0m
|
$34.5m
|
($6.0m)
|
$4.9m
|
($696k)
|
|
Proceeds from debt refinancing
|
|
—
|
—
|
$0
|
$0
|
$50.0m
|
$0
|
|
Payments of debt issuance costs
|
|
$5.6m
|
$0
|
$4.9m
|
($1.2m)
|
$0
|
$0
|
|
Issuance of common shares in partial settlement of 2025 Convertible Debt
|
|
—
|
—
|
—
|
$0
|
$0
|
$15.1m
|
|
Payment of debt discount
|
|
—
|
—
|
$0
|
$0
|
($11.8m)
|
$0
|
|
Repurchase of common stock withheld for taxes
|
|
$63k
|
$534k
|
$468k
|
($1.0m)
|
($3.7m)
|
($10.9m)
|
|
Net cash provided by (used in) financing activities
|
|
$126.1m
|
$27.2m
|
$127.5m
|
($1.6m)
|
$36.2m
|
$11.4m
|
|
Net cash provided by (used in) in cash, cash equivalents and restricted cash
|
|
—
|
$29.7m
|
$59.0m
|
($54.6m)
|
$4.1m
|
$39.3m
|
|
Cash, cash equivalents and restricted cash, beginning of year
|
|
—
|
$67.3m
|
$126.3m
|
$71.7m
|
$75.7m
|
$115.1m
|
|
Cash and cash equivalents
|
|
$37.6m
|
$67.3m
|
$122.0m
|
$67.4m
|
$71.6m
|
$111.0m
|
|
Cash paid for interest
|
|
$4.6m
|
$7.3m
|
$10.9m
|
$27.7m
|
$26.9m
|
$27.1m
|